Company intelligence / Profile preview

vivoPharm

Hummelstown/Hershey area, Pennsylvania, United Statesvivopharm.com ↗

Ownership: Private
Development stage: Other

Overview

vivoPharm provides specialized preclinical contract research services with expertise in oncology and immuno-oncology. The company offers more than 70 fully characterized cancer cell lines, proprietary orthotopic tumor modeling techniques, syngeneic mouse tumor models, flow cytometry services, and tailored in vitro/in vivo pharmacology studies. In November 2022, the U.S. operations were acquired by Reaction Biology to expand their integrated drug discovery solutions. No clinical results as it does not develop its own drugs.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologicMonoclonal antibodyCell therapy
Industry: Drug Discovery Services

Partnerships

Serves global pharma/biotech clients as CRO partner

Beyond the preview

Go deeper on vivoPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on vivoPharm.

Explore the full profile